The suppression of NF-κB and IL-1β also overlaps with the pathogenic drivers of psoriasis, suggesting that BCP’s keratinocyte effects may extend to multiple chronic inflammatory dermatoses. This evidence concerns the gene NFKB1 and psoriasis.